Evolution of Adaptive Immunity
适应性免疫的进化
基本信息
- 批准号:9899205
- 负责人:
- 金额:$ 38.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-15 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdultAffinityAmphibiaAnimalsAntibodiesAntibody ResponseAntigen PresentationAntigen ReceptorsAntigen-Presenting CellsAntigensAreaAutoimmunityB-Lymphocyte SubsetsB-LymphocytesBacteriaBindingBinding SitesBirdsBloodCarbohydratesCellsCommunicable DiseasesCrystallizationDataDendritic CellsDevelopmentEvolutionFishesFollicular Dendritic CellsGenesGrowthHistocompatibility Antigens Class IIHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunizationImmunoglobulin GenesImmunoglobulin MImmunoglobulinsImmunologyJawLampreysLicensingLicensing FactorLightLymphocyteLymphoid TissueMajor Histocompatibility ComplexMalignant NeoplasmsMalpighian corpusclesMammalsModelingMovementMucosal ImmunityMusNewborn AnimalsOsteichthyesPhenotypeRanaReptilesResearchSharkSpecificityStructureSurfaceT-Cell ReceptorT-LymphocyteTestingTimeTissuesTumor Necrosis Factor-BetaVertebratesWorkadaptive immune responseadaptive immunitybasechemokinecold blooded vertebratecomparativefightingjuvenile animalprospectiveresponse
项目摘要
SUMMARY
Studies of nonmammalian vertebrates (fish, amphibians, reptiles, and birds) have provided
essential discoveries in adaptive immunity, especially regarding lymphocyte lineages, origins of
the major histocompatibility complex (MHC), mucosal immunity, and antigen receptors. From
work that we have done in sharks, the oldest living vertebrates with immunoglobulins, T cell
receptors and the MHC, we hypothesize that the mammalian B1 cell paradigm is operable in
neonatal and young animals. Sharks also have antibodies with invariant binding sites (germline-
joined gene-encoded antibodies), which are expressed in secretory B cells but not in naïve B
cells. The antibody is modeled to have an unusual binding site, it binds to self tissues and
bacteria, and it is proposed to be a model for B1-derived antibodies in mammals. A second
wave of shark B cells with a unique immunoglobulin repertoire (also B1-like, with little N-region
addition) forms the nascent splenic white pulp, also proposed to be the paradigm for all
vertebrates, which we will test in mice and amphibians. Regarding humoral immune responses,
it is well known that nonmammalian vertebrates have poor affinity maturation of the antibody
response and seem to lack follicular dendritic cells (FDC); thus the mechanism of how native
antigen is presented to B cells is poorly understood. We have re-identified an antigen presenting
cell (APC) in frogs that expresses high levels of MHC class II, and yet presents native antigen
on its surface in the center of B cell follicles relatively late after immunization. We hypothesize
that these APC perform a `double-duty,' presenting antigen to both T cells and B cells. Our data
suggest that T cells are stimulated by these APC early in a response, and then the activated T
cells license the APC to stop degrading antigen, upregulate B cell chemokines (cxcl13), and
enter the follicle to present antigen to specific B cells. We hypothesize that this cell represents
the paradigm for humoral responses in cold-blooded vertebrates, and that conventional
mammalian DC can take on this `double-duty' phenotype in particular immune responses.
概括
对非哺乳动物脊椎动物(鱼类,两栖动物,爬行动物和鸟类)的研究已提供
适应性免疫学的基本发现,尤其是关于淋巴细胞谱系的基本发现,起源于
主要的组织相容性复合物(MHC),粘膜免疫和抗原受体。从
我们在鲨鱼中所做的工作,这是具有免疫球蛋白的最古老的活脊椎动物,T细胞
接收器和MHC,我们假设哺乳动物B1细胞范式可在
新生儿和年轻动物。鲨鱼还具有具有不变结合位点的抗体(种系 -
加入基因编码的抗体),该抗体在秘密B细胞中表达,但在幼稚的B中不表达
细胞。该抗体的建模为具有不寻常的结合位点,它与自我组织结合和
细菌,并被认为是哺乳动物中B1衍生抗体的模型。第二
带有独特免疫球蛋白库的鲨鱼B细胞波(也类似于B1,很少有N区域)
另外)形成新生的脾质纸浆,也建议是所有人的范式
脊椎动物,我们将在小鼠和两栖动物中进行测试。关于体液免疫反应,
众所周知,非乳腺脊椎动物的亲和力成熟较差
反应并似乎缺乏卵泡树突状细胞(FDC);因此,本地的机制
抗原呈现给B细胞的理解很少。我们已经重新确定了抗原呈现
表达高水平MHC II的青蛙中的细胞(APC),但呈现天然抗原
在免疫后,在B细胞四菌中心的表面上。我们假设
这些APC执行了“双重”,向T细胞和B细胞呈现抗原。我们的数据
表明T细胞在响应的早期就被这些APC刺激,然后激活的T
细胞许可APC停止降解抗原,上调B细胞趋化因子(CXCL13)和
输入卵泡以呈现特定B细胞的抗原。我们假设该单元代表
冷血脊椎动物的体液反应的范例,以及那个常规的
哺乳动物的DC可以尤其是免疫反应来处理这种“双层”表型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin F Flajnik其他文献
Martin F Flajnik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin F Flajnik', 18)}}的其他基金
Highly Stable, Anthrax-specific Shark Antibody Fragment
高度稳定的炭疽特异性鲨鱼抗体片段
- 批准号:
6771109 - 财政年份:2003
- 资助金额:
$ 38.63万 - 项目类别:
Highly Stable, Anthrax-specific Shark Antibody Fragment
高度稳定的炭疽特异性鲨鱼抗体片段
- 批准号:
6675141 - 财政年份:2003
- 资助金额:
$ 38.63万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an anti-idiotype based vaccine for respiratory syncytial virus
呼吸道合胞病毒抗独特型疫苗的研制
- 批准号:
10414112 - 财政年份:2021
- 资助金额:
$ 38.63万 - 项目类别:
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion
利用遗传密码扩展开发针对尤文肉瘤的骨靶向抗体
- 批准号:
10600106 - 财政年份:2021
- 资助金额:
$ 38.63万 - 项目类别:
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion
利用遗传密码扩展开发针对尤文肉瘤的骨靶向抗体
- 批准号:
10383663 - 财政年份:2021
- 资助金额:
$ 38.63万 - 项目类别:
Amyloid-inspired Vaccine Delivery for the Elderly
为老年人提供淀粉样蛋白疫苗
- 批准号:
10300848 - 财政年份:2021
- 资助金额:
$ 38.63万 - 项目类别:
Structure-function analysis of Mullerian Inhibiting Substance (MIS)
苗勒管抑制物质(MIS)的结构-功能分析
- 批准号:
10471277 - 财政年份:2021
- 资助金额:
$ 38.63万 - 项目类别: